Oncolytics Biotech annual operating margin
2017
2018
Oncolytics Biotech's operating margin was −3,153.65% for fiscal 2018.
View full Oncolytics Biotech company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2018 | 2018-12-31 | −3,153.65% | −2901.24 pp |
| 2017 | 2017-12-31 | −252.41% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|
Across the available reported history, Oncolytics Biotech's operating margin decreased from −252.41% to −3,153.65%, a change of −2901.24 percentage points.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oncolytics Biotech filings at SEC.gov ↗